Transforaminal Epidural Injection in Acute Sciatica
C.L.A.Vleggeert-Lankamp
142 participants
Jun 1, 2019
INTERVENTIONAL
Conditions
Summary
Patients suffering from sciatica are treated conservatively for the first 8 weeks due to the favourable prognosis. This period is preferably extended up to 14-16 weeks after which patients may opt for surgery. However, patients may experience severe discomfort due to pain in the leg which can lead to decreased physical activity and socio-economic problems. An adequate therapy to alleviate symptoms during this period of 'wait-and-see' is lacking. In this study, patients will be randomized to treatment with transforaminal epidural injections or standard oral pain medication.
Eligibility
Inclusion Criteria3
- Diagnosed with sciatica by GP
- NRS leg pain of 6 or more on a 10-point NRS scale
- Minimum duration of symptoms of 3 weeks and maximum duration of 8 weeks
Exclusion Criteria7
- Age under 18 years
- Condition preventing to receive transforaminal epidural injection
- Severe scoliosis
- Transforaminal epidural injection received in 6 months before randomization date
- Surgery for sciatica at the same level
- Surgery for sciatica at another level within one year before inclusion
- Pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
In combination with dexamethasone or methylprednisolone acetate
In combination with lidocaine
In combination with lidocaine
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03924791